Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis

NCT02083263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2014-07-16

Study results available
· View outcomes & findings →

Summary

With the use of Non invasive ventilation the patients with cystic fibrosis will have better lung function (FEV1).

Conditions

Interventions

DEVICE

Bilevel

3 months

DEVICE

PEP mask

3 months

Sponsors & Collaborators

Principal Investigators

  • Cecilia Rodriguez, Physio · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02083263 on ClinicalTrials.gov